Mon 3/18/2019 11:43 ET
S&P 5002824.211.690.06%BANKS450.725.771.28%OIL59.270.450.76%BITCOIN3984.4613.550.34%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Stocks For A Different Jungle (Essa Pharma - EPIX)    If it belongs at the Pit it doesn't belong here.

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add EPIX
From: singhtelecom (Rep: 959)Date: 05/01/2017 22:52
Forum: Stocks For A Different Jungle - Msg #19107 - List EPIX msgs Thread #673924524 (Rec: 0)
ESSA intends to submit data from the Phase 1 clinical trial to a scientific meeting and anticipates announcing updated results by the end of the second calendar quarter of 2017.

"We are very pleased with the progress of our Phase 1 study to date," said David Parkinson, President and CEO of the Company. "The excellent tolerability of EPI-506 has allowed us to continue escalating the dose safely to achieve therapeutically meaningful exposures to the drug. Our focus now is to augment our data set as we finalize Phase 2 dose selection and prepare to progress into the Phase 2 portion of the study."

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser singhtelecom: Reward | Watch | IgnoreEPIX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add EPIX | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999-, Inc.